T Acute Lymphoblastic Leukemia - ADE - SET-NUP214 fusion

Association details:

Biomarker:	SET-NUP214 fusion
Cancer:	T Acute Lymphoblastic Leukemia
Regimen:	ADE (cytarabine + daunorubicin + etoposide IV)
Direction:	Sensitive

Evidence:

Evidence Level:

Sensitive: C4 – Case Studies

Source:

Front Oncol

Title:

Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With SET-CAN/NUP214 Fusion: Perspectives From a Case Report and Literature Review

Published date:

03/26/2021

Excerpt:

Here, we present the treatment process of an illuminating case of T-ALL with SET-CAN/NUP214 fusion….The patient received DAE regimen chemotherapy, and finally achieved complete remission and received allogenic hematopoietic stem cell transplantation (allo-HSCT).

DOI:

10.3389/fonc.2021.651494